Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability and Bioequivalence Studies submitted in NDAs and INDs" training has been added to ResearchAndMarkets.com's offering. Attendees that need ...

A draft guidance document provides recommendations for submitting bioavailability information in investigational new drug and new drug applications. FDA published draft guidance on Feb. 25, 2019 on ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability and Bioequivalence Studies submitted in NDAs and INDs" training has been added to ...

The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...

Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while significant ...

Health Canada has released a new draft guidance document proposing to allow the waiver of bioavailability studies in support of marketing authorization applications for immediate-release, ...